Suppressing GDF15 enhances the chemotherapeutic effect of 5 FU on MSI-H CRC by regulating the ferroptosis pathway SLC7A11/GSH/GPX4
Zhi min Huang Fu, Ming Xiao, Hailun Xie, Shuxian Zhang, Tang Yi, Qingshu Li, Ming Li, Yalan Wang · 2024
Read Suppressing GDF15 enhances the chemotherapeutic effect of 5 FU on MSI-H CRC by regulating the ferroptosis pathway SLC7A11/GSH/GPX4 by Zhi min Huang Fu, Ming Xiao, Hailun Xie, Shuxian Zhang, Tang Yi, Qingshu Li, Ming Li, Yalan Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621149.txt.
Description
Zhi Fu and seven co-authors found that blocking a growth factor can boost a standard drug in a hard type of bowel cancer in a 2024 study. The factor, GDF15, runs high in many cancers and in this bowel type, which is marked by unstable DNA repeats. Its exact role there was unclear.
Levels ran high in patient tissue and in two cell lines of this type. Silencing the factor slowed cell growth. It also made cells more open to the drug, with more cell death. In mice, tumors with the factor silenced shrank more under the drug. The team traced the effect to a cell death path driven by iron and a set of protective proteins. The factor may serve as both a marker and a target.
Catalog record
| CREATOR | Zhi min Huang Fu, Ming Xiao, Hailun Xie, Shuxian Zhang, Tang Yi, Qingshu Li, Ming Li, Yalan Wang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |